Reporting Owner Activity for Suganthi Balasubramanian

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Linked issuers

1

Largest position

BioXcel Therapeutics, Inc.

Disclosed value

$187.11M

Transaction activity

Available

Ownership signals 1 signal
Forms 3/4/5 position snapshot

Estimated Forms 3/4/5 value

$187.11M

Estimated from Forms 3/4/5 when filings include enough holding data.

Issuers linked to this owner

1

Distinct issuers connected to this reporting owner in parsed SEC filings.

Latest parsed owner filing

14 Apr 2023

Most recent owner-level filing date in the parsed SEC record.

How to read Forms 3/4/5 positions
  • Reported values are estimates from parsed SEC Forms 3/4/5 when the filing includes enough price and share data.
  • Use this as a filing-backed owner snapshot, not as a live cap table.
Identity 1 identity field
Location
Guilford, CT
SEC source record 1 source field
Latest reporting-owner signature
/s/ Suganthi Balasubramanian
Source evidence 1 source field
SEC filing history
Open SEC filing history

Follow Filing Activity

Follow Suganthi Balasubramanian and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Suganthi Balasubramanian

Recent insider transactions for Suganthi Balasubramanian

Sym Company Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .